You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKesson
Moodys
Express Scripts
Boehringer Ingelheim
Merck
Dow

Last Updated: August 11, 2020

DrugPatentWatch Database Preview

Vecuronium bromide - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for vecuronium bromide and what is the scope of freedom to operate?

Vecuronium bromide is the generic ingredient in two branded drugs marketed by Organon Usa Inc, Aurobindo Pharma Ltd, Gland Pharma Ltd, Hikma, Hospira, Mylan Labs Ltd, Sagent Pharms Inc, Sun Pharm, Teva Pharms Usa, Watson Labs, and West-ward Pharms Int, and is included in thirteen NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for vecuronium bromide. Nine suppliers are listed for this compound.

Recent Clinical Trials for vecuronium bromide

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyPhase 2/Phase 3
Merck Sharp & Dohme Corp.Phase 4
Craig CurryPhase 4

See all vecuronium bromide clinical trials

Pharmacology for vecuronium bromide
Medical Subject Heading (MeSH) Categories for vecuronium bromide
Paragraph IV (Patent) Challenges for VECURONIUM BROMIDE
Tradename Dosage Ingredient NDA Submissiondate
NORCURON INJECTABLE;INJECTION vecuronium bromide 018776

US Patents and Regulatory Information for vecuronium bromide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Labs Ltd VECURONIUM BROMIDE vecuronium bromide INJECTABLE;INJECTION 090243-002 May 11, 2010 AP RX No No   Start Trial   Start Trial   Start Trial
Hospira VECURONIUM BROMIDE vecuronium bromide INJECTABLE;INJECTION 075558-001 Sep 11, 2001 DISCN No No   Start Trial   Start Trial   Start Trial
West-ward Pharms Int VECURONIUM BROMIDE vecuronium bromide INJECTABLE;INJECTION 075549-002 Jun 13, 2000 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for vecuronium bromide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Organon Usa Inc NORCURON vecuronium bromide INJECTABLE;INJECTION 018776-002 Apr 30, 1984   Start Trial   Start Trial
Organon Usa Inc NORCURON vecuronium bromide INJECTABLE;INJECTION 018776-002 Apr 30, 1984   Start Trial   Start Trial
Organon Usa Inc NORCURON vecuronium bromide INJECTABLE;INJECTION 018776-002 Apr 30, 1984   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Moodys
Mallinckrodt
Merck
Harvard Business School
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.